Cabergoline
- Product NDC
- 50090-7642
- 11-digit product format
- 500907642
- Labeler code
- 50090
- Product ID
- 50090-7642_f0d4a3cf-7de2-4959-b8b6-a2753d0deb15
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cabergoline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA218618
- Marketing category
- ANDA
- Marketing start
- 2024-10-03
- Substance
- CABERGOLINE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Ergolines [CS], Ergot Derivative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cabergoline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CABERGOLINE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LL60K9J05T |
| Rxcui | 199703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7642-0 | Cabergoline | 8 in 1 BOTTLE | TABLET | 8 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7642-0 | 50090764200 | 8 TABLET in 1 BOTTLE (50090-7642-0) | 8 tablet | 2025-08-26 | No | No | Current |